04.07.2024
Deal: Wenger Vieli acted as Swiss legal advisor to NLS Pharmaceutics
22.03.2024
Deal: Wenger Vieli acted as Swiss legal advisor to NLS Pharmaceutics
20.12.2023
Deal: Wenger Vieli advised the sellers of Swiss Dental Solutions Group on the sale of its majority stake shareholding
20.09.2023
Deal: Wenger Vieli advised sell-side in the sale transaction of EXALOS to indie Semiconductor
07.09.2023
Deal: Wenger Vieli advised Axa Venture Partners on its investment in Deskbird's Series A financing round
07.07.2023
Deal: Wenger Vieli advised the Sellers of Seervision on the sale to QSC LLC
13.12.2022
Deal: Wenger Vieli acted as Swiss legal advisor to NLS Pharmaceutics
07.11.2022
Wenger Vieli advises LatticeFlow on closing of its Series A financing round of USD 12m
07.10.2022
Deal: Wenger Vieli advised NLS Pharmaceutics on a Private Placement Transaction
28.09.2022
DEAL: Wenger Vieli advised the shareholders of MENU Technologies in a cross-border transaction
27.04.2022
Deal: NLS Pharmaceutics closes of a USD 4.4m registered direct offering
26.04.2022
Deal: Fu-Gen secures EUR 320m funding deal
16.11.2021
Deal: Investment in Home Instead Group by Unigestion SA
13.08.2021
Deal: Advisor to Atlas Antibodies